Zantac Recall Update: Potential Zantac Cancer Risk from NDMA
New test results from an independent lab are increasing pressure on the FDA to issue a blanket Zantac recall. In October 2019, the FDA warned that Zantac (otherwise known by its generic name, ranitidine) may contain elevated levels of NDMA, a chemical that can potentially cause cancer.
A Zantac recall has not yet been issued, however recent testing raises significant concern about the safety of the common drug.
Emery Pharma, an independent testing lab in California, has filed a Citizen Petition urging the FDA to recall Zantac after it found that “NDMA accumulates in ranitidine-containing drug products on exposure to elevated temperatures.”
According to a statement from the lab, “While NDMA levels in ranitidine may be acceptable at the source, they may not be so when the drug is purchased and subsequently at the time of consumption by the consumer.”
Following the FDA’s initial announcement, several generic ranitidine manufacturers have issued voluntary recalls of the popular medication, often used to treat heartburn and stomach ulcers.
Sanofi, which manufacturers Zantac, has not yet issued a voluntary Zantac recall covering its brand-name drug as of January 2020.
Riddle & Brantley’s Zantac lawsuit attorneys have been investigating these claims. If you’ve taken Zantac and been diagnosed with cancer, call 1-800-525-7111 to speak with our legal team. The consultation is FREE and there are no attorney fees unless we win your case — and you receive financial compensation.
Is a Zantac recall coming soon?
While several ranitidine manufacturers have issued voluntary recalls, there is no Zantac recall affecting the popular brand-name drug.
The pressure to act is growing.
In response to FDA reports, major pharmacies including Walgreen’s, CVS and Rite Aid voluntarily pulled Zantac and other ranitidine drugs from their shelves in 2019.
Zantac is sold over-the-counter (OTC) and according to the World Health Organization is one of the world’s 50 most popular medicines.
Does Zantac cause cancer? What should I do if I take Zantac?
While tests have not established a direct causal link between Zantac and cancer, independent labs have found Zantac to be contaminated with high levels of NDMA. NDMA, which stands for N-nitrosodimethylamine, is a known carcinogen, meaning it can cause cancer.
According to the FDA:
“NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests.”
A 2016 study found that patients taking ranitidine excreted significant levels of NDMA in their urine over 24 hours after taking the drug.
The FDA, however, has not issued a Zantac recall and is not advising consumers to stop taking the drug… yet.
If you’re taking Zantac, we encourage you to talk with your doctor about potential cancer risk.
Have you taken Zantac and been diagnosed with cancer?
Even without a blanket Zantac recall, this drug may still be dangerous.
If you have taken Zantac and been diagnosed with cancer, Zantac may be responsible — and you may be entitled to financial compensation. Contact a Zantac lawsuit lawyer at Riddle & Brantley for a FREE consultation at 1-800-525-7111.
There is no obligation and there are no upfront costs or attorney fees unless we win your case.
Call 1-800-525-7111 today and let’s talk. You can also complete the fast and easy form below if you prefer.
If you’ve been diagnosed with cancer after taking Zantac, you may be entitled to financial compensation — and you deserve justice.